13F-HR filed by Krensavage Asset Management, LLC
Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-12, with 20 holding rows worth $277,542,000.
- Accession
- 0001609251-16-000010
- Filer
- CIK 1609251
- Filed
- 2016-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2016
A holdings report, 20 entries on the cover page, a total value of $277,542,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $277,542,000 with VALUE read as thousands by filing date, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 275,248 | $29,154,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 646,446 | $27,409,000 | thousands by filing date | |
| IMPAX LABORATORIES INC | 45256B101 | COM | 730,817 | $21,062,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 906,930 | $19,998,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 396,545 | $19,918,000 | thousands by filing date | |
| AMGEN INC. | 31162100 | COM | 125,802 | $19,141,000 | thousands by filing date | The CUSIP as filed is malformed. |
| HALYARD HEALTH INC | 40650V100 | COM | 575,206 | $18,706,000 | thousands by filing date | |
| SUCAMPO PHARMACEUTICALS-CL A | 864909106 | CL A | 1,631,398 | $17,896,000 | thousands by filing date | |
| INDIVIOR PLC ORD | G4766E108 | Common Stock | 4,727,970 | $15,800,000 | thousands by filing date | |
| CONMED CORP COM | 207410101 | Stock | 329,142 | $15,710,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 257,538 | $14,837,000 | thousands by filing date | |
| RTI BIOLOGICS INC | 74975N105 | COM | 3,648,001 | $13,096,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 63,166 | $11,628,000 | thousands by filing date | |
| INVACARE CORP | 461203101 | COMMON STOCK | 901,440 | $10,934,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 26,416 | $6,104,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 217,904 | $4,275,000 | thousands by filing date | |
| AVIRAGEN THERAPEUTICS INC | 53761102 | COM | 2,708,438 | $3,791,000 | thousands by filing date | The CUSIP as filed is malformed. |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 910,703 | $3,588,000 | thousands by filing date | |
| DIGIRAD CORP | 253827109 | COM | 481,218 | $2,478,000 | thousands by filing date | |
| JUNIPER PHARMACEUTICALS INC COM | 48203L107 | Stock | 287,755 | $2,017,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001609251-16-000010 | this filing | 2016-08-12 | acceptance time not in the bulk data set |